Correlation Between Bombay Burmah and Beta Drugs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bombay Burmah and Beta Drugs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bombay Burmah and Beta Drugs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bombay Burmah Trading and Beta Drugs, you can compare the effects of market volatilities on Bombay Burmah and Beta Drugs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bombay Burmah with a short position of Beta Drugs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bombay Burmah and Beta Drugs.

Diversification Opportunities for Bombay Burmah and Beta Drugs

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Bombay and Beta is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Bombay Burmah Trading and Beta Drugs in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Beta Drugs and Bombay Burmah is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bombay Burmah Trading are associated (or correlated) with Beta Drugs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Beta Drugs has no effect on the direction of Bombay Burmah i.e., Bombay Burmah and Beta Drugs go up and down completely randomly.

Pair Corralation between Bombay Burmah and Beta Drugs

Assuming the 90 days trading horizon Bombay Burmah Trading is expected to generate 1.01 times more return on investment than Beta Drugs. However, Bombay Burmah is 1.01 times more volatile than Beta Drugs. It trades about -0.09 of its potential returns per unit of risk. Beta Drugs is currently generating about -0.1 per unit of risk. If you would invest  252,360  in Bombay Burmah Trading on October 26, 2024 and sell it today you would lose (29,140) from holding Bombay Burmah Trading or give up 11.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Bombay Burmah Trading  vs.  Beta Drugs

 Performance 
       Timeline  
Bombay Burmah Trading 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bombay Burmah Trading has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Beta Drugs 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Beta Drugs are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Beta Drugs may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Bombay Burmah and Beta Drugs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bombay Burmah and Beta Drugs

The main advantage of trading using opposite Bombay Burmah and Beta Drugs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bombay Burmah position performs unexpectedly, Beta Drugs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Beta Drugs will offset losses from the drop in Beta Drugs' long position.
The idea behind Bombay Burmah Trading and Beta Drugs pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios